FinalDose
YC X26 ↗London, GB · Founded 2025 · 5 employees · 4 known investors
FinalDose develops a programmable DNA-targeting molecule designed to recognize and destroy cells carrying specific genetic sequences, with initial applications in oncology across cancer types.
AI & Machine LearningBiotechHealthtechArtificial IntelligenceGene TherapyTherapeuticsGenetic Engineeringin /finaldose/@LaunchFD2026ycombinator.com ↗
Founders & leadership· Y Combinator alumni (X26)
Investors · 4
Companies House · registry record
View on Companies House ↗- Registered name
- FINALDOSE LTD
- Company number
- 16816175
- Status
- Active
- Company type
- Private limited company
- Incorporated
- 28 Oct 2025
- Registered office
- 3rd Floor 1 Ashley Road, Altrincham, Cheshire, WA14 2DT
- Nature of business (SIC)
- 72110 — Research and experimental development on biotechnology
- Accounts
- next due 28 Jul 2027
- Confirmation statement
- next due 10 Nov 2026
Current officers · 1
- Shang-Kuan Lin — director, appointed 28 Oct 2025
Source: Companies House public register · retrieved 24 Jul 2026. Contains public sector information licensed under the Open Government Licence v3.0.
In the news
- FinalDose: The first programmable drug to cure all cancersycombinator.com · 2026
- FinalDose Funding | Complete Analysis | Extruct AIextruct.ai